Syncona Ltd (LON:SYNC), a leading healthcare company focused on founding, building and funding global leaders in life science, today announces the merger of its companies, Gyroscope Therapeutics (Gyroscope), an ophthalmology ...

Syncona Ltd (LON:SYNC), a leading healthcare company focused on founding, building and funding global leaders in life science, today notes that its portfolio company, Autolus Therapeutics plc has filed a ...

Syncona Ltd (LON:SYNC), a leading healthcare company focused on founding, building and funding global leaders in life science, today noted the announcement from its company, Nightstar Therapeutics Plc (NASDAQ:NITE) (Nightstar), ...

Syncona Ltd (LON:SYNC) announced a CHF 28 million (£21.4 million) commitment to Anaveon, a new immuno-oncology company, in a CHF 35 million (£26.8 million) Series A financing alongside the Novartis ...

Syncona Ltd (LON:SYNC), a leading healthcare company focused on founding, building and funding global leaders in life science, today issues its quarterly update covering the period from 1 October to ...

Syncona Limited (LON:SYNC), today announced Interim Results for the six months ended 30 September 2018. Life science companies continue to drive strong returns and increase in NAV · Net assets ...